TECHNOLOGY COST SHOULD BE FACTOR IN NATIONAL COVERAGE DECISIONS, PPRC SUGGESTS; NEW COVERAGE CATEGORY FOR EXPERIMENTAL TREATMENTS ALSO SOUGHT
This article was originally published in The Gray Sheet
Executive Summary
National coverage decisions for medical technology should be made on the basis of cost as well as safety and efficacy considerations, the Physician Payment Review Commission suggests in its 1994 annual report submitted to Congress March 31.